NO941150L - Tiadiazinoner - Google Patents
TiadiazinonerInfo
- Publication number
- NO941150L NO941150L NO941150A NO941150A NO941150L NO 941150 L NO941150 L NO 941150L NO 941150 A NO941150 A NO 941150A NO 941150 A NO941150 A NO 941150A NO 941150 L NO941150 L NO 941150L
- Authority
- NO
- Norway
- Prior art keywords
- atoms
- independently
- hal
- thiadiazinone
- tiadiazinones
- Prior art date
Links
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 abstract 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000000 cycloalkoxy group Chemical group 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- -1 methylenedioxy Chemical group 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4310699A DE4310699A1 (de) | 1993-04-01 | 1993-04-01 | Thiadiazinone |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO941150D0 NO941150D0 (no) | 1994-03-29 |
| NO941150L true NO941150L (no) | 1994-10-03 |
Family
ID=6484473
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO941150A NO941150L (no) | 1993-04-01 | 1994-03-29 | Tiadiazinoner |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5434149A (cs) |
| EP (1) | EP0618201A1 (cs) |
| JP (1) | JPH072812A (cs) |
| CN (1) | CN1101644A (cs) |
| AU (1) | AU675488B2 (cs) |
| CA (1) | CA2120301A1 (cs) |
| CZ (1) | CZ70594A3 (cs) |
| DE (1) | DE4310699A1 (cs) |
| HU (1) | HUT70543A (cs) |
| NO (1) | NO941150L (cs) |
| SK (1) | SK38594A3 (cs) |
| TW (1) | TW310326B (cs) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19500558A1 (de) * | 1995-01-11 | 1996-07-18 | Merck Patent Gmbh | 3-Alkoxycarbonyl-thiadiazinone |
| DE19502699A1 (de) * | 1995-01-28 | 1996-08-01 | Merck Patent Gmbh | Arylalkyl-thiadiazinone |
| DE19533975A1 (de) * | 1995-09-14 | 1997-03-20 | Merck Patent Gmbh | Arylalkyl-diazinone |
| AU2001284792A1 (en) * | 2000-08-10 | 2002-02-25 | Cold Spring Harbor Laboratory | Augmented cognitive training |
| US8153646B2 (en) * | 2000-08-10 | 2012-04-10 | Dart Neuroscience (Cayman) Ltd. | Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation |
| CA2437932A1 (en) * | 2001-02-12 | 2002-09-19 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Use of type 4 phosphodiesterase inhibitors in myocardial diseases |
| DE10150517A1 (de) * | 2001-10-12 | 2003-04-17 | Merck Patent Gmbh | Verwendung von Phosphodiesterase IV-Inhibitoren |
| EP1463509A1 (en) * | 2001-10-31 | 2004-10-06 | MERCK PATENT GmbH | Type 4 phosphodiesterase inhibitors and uses thereof |
| CA2554797C (en) | 2004-02-04 | 2012-09-04 | Altana Pharma Ag | 2-(piperidin-4-yl)-4,5-dihydro-2h-pyridazin-3-one derivatives as pde4 inhibitors |
| EP1716123A1 (en) * | 2004-02-04 | 2006-11-02 | Altana Pharma AG | Pyridazinone derivatives and their use as pde4 inhibitors |
| DE102007041115A1 (de) | 2007-08-30 | 2009-03-05 | Merck Patent Gmbh | Thiadiazinonderivate |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4413713Y1 (cs) * | 1967-04-26 | 1969-06-09 | ||
| JPS54135785A (en) * | 1978-04-12 | 1979-10-22 | Yoshitomi Pharmaceut Ind Ltd | Pyridazinone derivative and its preparation |
| US4495185A (en) * | 1981-11-12 | 1985-01-22 | Imperial Chemical Industries, Plc | 1,2,4-Triazin-3(2H) ones |
| US4489074A (en) * | 1982-11-12 | 1984-12-18 | Imperial Chemical Industries, Plc | 1,3,4-Thiadiazin-2-ones |
| ES2131506T3 (es) * | 1990-09-21 | 1999-08-01 | Rohm & Haas | Dihidropiridacinonas y piridacinonas como fungicidas. |
-
1993
- 1993-04-01 DE DE4310699A patent/DE4310699A1/de not_active Withdrawn
-
1994
- 1994-03-19 EP EP94104349A patent/EP0618201A1/de not_active Withdrawn
- 1994-03-23 AU AU57983/94A patent/AU675488B2/en not_active Expired - Fee Related
- 1994-03-25 CZ CZ94705A patent/CZ70594A3/cs unknown
- 1994-03-28 JP JP6057099A patent/JPH072812A/ja active Pending
- 1994-03-29 NO NO941150A patent/NO941150L/no unknown
- 1994-03-30 CN CN94104074A patent/CN1101644A/zh active Pending
- 1994-03-30 TW TW083102744A patent/TW310326B/zh active
- 1994-03-30 CA CA002120301A patent/CA2120301A1/en not_active Abandoned
- 1994-03-31 HU HU9400934A patent/HUT70543A/hu unknown
- 1994-03-31 SK SK385-94A patent/SK38594A3/sk unknown
- 1994-03-31 US US08/220,657 patent/US5434149A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE4310699A1 (de) | 1994-10-06 |
| TW310326B (cs) | 1997-07-11 |
| JPH072812A (ja) | 1995-01-06 |
| AU5798394A (en) | 1994-10-06 |
| US5434149A (en) | 1995-07-18 |
| HUT70543A (en) | 1995-10-30 |
| CA2120301A1 (en) | 1994-10-02 |
| AU675488B2 (en) | 1997-02-06 |
| CN1101644A (zh) | 1995-04-19 |
| NO941150D0 (no) | 1994-03-29 |
| CZ70594A3 (en) | 1994-12-15 |
| HU9400934D0 (en) | 1994-06-28 |
| EP0618201A1 (de) | 1994-10-05 |
| SK38594A3 (en) | 1994-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO965305L (no) | Nye forbindelser, fremgangsmåter ved deres fremstilling og anti-tumormidler | |
| DK0850926T3 (da) | Difluorprostaglandinderivater og deres anvendelse | |
| NO904569D0 (no) | Benzimidazolderivater og fremgangsmaate for deres fremstilling. | |
| NO941150L (no) | Tiadiazinoner | |
| DK0791006T3 (da) | Polyanioniske benzylglylcosider som inhibitorer af proliferation af glatte muskelceller | |
| NO913725D0 (no) | Benzen-, pyridin- og pyrimidin-derivater og fremgangsmaatefor deres fremstilling. | |
| ES8203845A1 (es) | Procedimiento para preparar derivados de piridoxina | |
| DK0479546T3 (da) | Piperazinderivater | |
| AU539399B2 (en) | Substituted oxonicotinates | |
| ES2063300T3 (es) | Derivado de acido aminobencensulfonico. | |
| ATE93232T1 (de) | Bis(methylendioxy)biphenyl-verbindungen. | |
| DE69828284D1 (de) | Naphthyridinderivate oder salze davon | |
| TW352383B (en) | Hydroximic acid derivatives, processes for their preparation, and compositions comprising them | |
| DK0508740T3 (da) | Thiazolidindionderivater, deres fremstilling og anvendelse. | |
| FI852223A0 (fi) | Saosom fungicider anvaenda triazoler. | |
| NO20015832L (no) | Trisykliske kondenserte heterosyklus-forbindelser, fremgangsmåte for deres fremstilling og anvendelse derav | |
| NO934227L (no) | Pyrrolderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse | |
| HK10389A (en) | Thienopyridine derivatives | |
| ES2193047T3 (es) | (3,4 dihydro-2h-benzo(1,4) oxazinilmetil)(3-(1h-indol-3-il)-alquil)-aminas. | |
| AU2442488A (en) | Heterocyclically substituted n-sultamsulfonamides, process for their preparation and their use as herbicides and plant growth regulators | |
| FI883507A0 (fi) | Naftotiazepinderivat och deras framstaellning. | |
| NO941757L (no) | 1-fenylpyrrolidon-derivater med optisk aktivitet, mellomprodukter for fremstilling derav og fremgangsmåter for deres fremstilling |